This site is intended for healthcare professionals only
LoginRegister
CDSCO to Reject Long-Pending SUGAM Applications After 30 Days for Non-Response to QueriesCDSCO Introduces Online Export NOC System on SUGAM Portal
CDSCO Panel Rejects Hetero Labs Plea for Lenacapavir Approval Without Local TrialsHetero Labs Gets CDSCO Panel Nod To study Semaglutide Injection for Type 2 Diabetes Mellitus
Indoco Remedies CRO AnaCipher gets one Form 483 from USFDAIndoco Remedies CRO AnaCipher gets one Form 483 from USFDA
Nestle India under SEBI net, gets warning letterNestle India under SEBI net, gets warning letter
Jaipur Lon Hospital nursing staff accused of molesting ward helper, removed from duty28-Year-Old Pharma MD Accused of Molesting Senior Employee, FIR Registered
Sun Pharma to Invest Rs 500 Cr in Assam Manufacturing Plant, 500+ Jobs ExpectedSun Pharma to acquire Checkpoint Therapeutics for USD 355 million
Raid: Drugs worth Rs 80000 illegally stocked for sale seized at clinicRaid: Drugs worth Rs 80000 illegally stocked for sale seized at clinic
Zydus Lifesciences bags USFDA okay for Ketoconazole ShampooZydus Lifesciences bags USFDA okay for Ketoconazole shampoo for dandruff
Around 5,000 Small Pharma Units at Risk as Centre Enforces Tougher GMP NormsUSFDA successfully completes audit at JB Chemicals and Pharma Gujarat facility
Printing unit supplying wrappers for spurious medicines busted in DelhiPunjab police recovers over two lakh prohibited tablets, 4 arrested
BDR Pharmaceutical Gets CDSCO Panel Nod To Manufacture Market anticancer drug Tucatinib TabletsBDR Pharmaceutical Gets CDSCO Panel Nod To Manufacture Market anticancer drug Tucatinib Tablets
CDSCO Panel Approves BE Study for Alkems Dapagliflozin, Pioglitazone, Metformin FDC, Seeks Revised Phase III PlanAlkem Laboratories Gets CDSCO Panel Nod To study Semaglutide tablet for Type 2 Diabetes Mellitus
X